Pricing
Login
Home
Charts
Search
Watchlist
Products

Kilitch Drugs (India) Ltd

KILITCH
₹223.81-5.55%20 Nov 2026
Reports
Pharma Formulations

Kilitch Drugs (India) Ltd

KILITCH
₹223.81
-5.55%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹782Cr
Close
Close Price
₹223.81
Industry
Industry
Pharma Formulations
PE
Price To Earnings
32.16
PS
Price To Sales
3.28
Revenue
Revenue
₹239Cr
Rev Gr TTM
Revenue Growth TTM
13.87%
PAT Gr TTM
PAT Growth TTM
-13.59%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
324533475661434954904550
Growth YoY
Revenue Growth YoY%
6.1-1.4-8.515.276.736.629.03.0-4.246.34.02.7
Expenses
ExpensesCr
303832414747404448674244
Operating Profit
Operating ProfitCr
27269153562237
OPM
OPM%
7.115.85.012.815.623.87.610.311.424.76.513.3
Other Income
Other IncomeCr
303522372032
Interest Expense
Interest ExpenseCr
212012211112
Depreciation
DepreciationCr
111111111114
PBT
PBTCr
352108143962043
Tax
TaxCr
122234111522
PAT
PATCr
24096102841521
Growth YoY
PAT Growth YoY%
1.826.9-96.469.2222.4177.71,954.5-6.6-23.045.6-12.8-82.5
NPM
NPM%
5.58.20.318.110.016.75.216.48.016.64.42.8
EPS
EPS₹
0.91.10.42.61.83.20.92.51.34.20.80.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
324533475661434954904550
Growth YoY
Revenue Growth YoY%
6.1-1.4-8.515.276.736.629.03.0-4.246.34.02.7
Expenses
ExpensesCr
303832414747404448674244
Operating Profit
Operating ProfitCr
27269153562237
OPM
OPM%
7.115.85.012.815.623.87.610.311.424.76.513.3
Other Income
Other IncomeCr
303522372032
Interest Expense
Interest ExpenseCr
212012211112
Depreciation
DepreciationCr
111111111114
PBT
PBTCr
352108143962043
Tax
TaxCr
122234111522
PAT
PATCr
24096102841521
Growth YoY
PAT Growth YoY%
1.826.9-96.469.2222.4177.71,954.5-6.6-23.045.6-12.8-82.5
NPM
NPM%
5.58.20.318.110.016.75.216.48.016.64.42.8
EPS
EPS₹
0.91.10.42.61.83.20.92.51.34.20.80.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
212951825369114140154198235239
Growth
Revenue Growth%
10.336.578.061.7-35.428.566.722.210.628.518.713.9
Expenses
ExpensesCr
252946755363104122130167199201
Operating Profit
Operating ProfitCr
-4-15705101824313738
OPM
OPM%
-20.8-2.410.38.50.47.69.112.615.715.915.515.9
Other Income
Other IncomeCr
31344333411117
Interest Expense
Interest ExpenseCr
000011156565
Depreciation
DepreciationCr
10102222243347
PBT
PBTCr
-12-96925101219343933
Tax
TaxCr
00151134610910
PAT
PATCr
-11-954146814253023
Growth
PAT Growth%
-3,766.920.6158.0-25.7-78.0347.365.033.363.983.718.3-13.6
NPM
NPM%
-53.3-31.010.14.61.65.55.45.98.812.612.59.5
EPS
EPS₹
-4.1-3.31.91.30.31.22.33.34.58.18.97.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
212951825369114140154198235239
Growth
Revenue Growth%
10.336.578.061.7-35.428.566.722.210.628.518.713.9
Expenses
ExpensesCr
252946755363104122130167199201
Operating Profit
Operating ProfitCr
-4-15705101824313738
OPM
OPM%
-20.8-2.410.38.50.47.69.112.615.715.915.515.9
Other Income
Other IncomeCr
31344333411117
Interest Expense
Interest ExpenseCr
000011156565
Depreciation
DepreciationCr
10102222243347
PBT
PBTCr
-12-96925101219343933
Tax
TaxCr
00151134610910
PAT
PATCr
-11-954146814253023
Growth
PAT Growth%
-3,766.920.6158.0-25.7-78.0347.365.033.363.983.718.3-13.6
NPM
NPM%
-53.3-31.010.14.61.65.55.45.98.812.612.59.5
EPS
EPS₹
-4.1-3.31.91.30.31.22.33.34.58.18.97.0
Sales CAGR
1 Year19%
3 Years19%
5 Years28%
TTM14%
EBITDA CAGR
1 Year16%
3 Years28%
5 Years48%
TTM20%
PAT CAGR
1 Year18%
3 Years53%
5 Years51%
TTM-14%
Avg. ROCE
1 Year12%
3 Years13%
5 Years11%
TTM10%
CFO / EBITDA
1 Year65%
3 Years43%
5 Years40%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131314151515161616163535
Reserves
ReservesCr
958896106103112121131160186245254
Current Liabilities
Current LiabilitiesCr
8121520227369696484122123
Non Current Liabilities
Non Current LiabilitiesCr
000000000285957
Total Liabilities
Total LiabilitiesCr
117113128144143203210220240313458464
Current Assets
Current AssetsCr
474963655680114126146174222210
Non Current Assets
Non Current AssetsCr
6964657987123969394139236254
Total Assets
Total AssetsCr
117113128144143203210220240313458464
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131314151515161616163535
Reserves
ReservesCr
958896106103112121131160186245254
Current Liabilities
Current LiabilitiesCr
8121520227369696484122123
Non Current Liabilities
Non Current LiabilitiesCr
000000000285957
Total Liabilities
Total LiabilitiesCr
117113128144143203210220240313458464
Current Assets
Current AssetsCr
474963655680114126146174222210
Non Current Assets
Non Current AssetsCr
6964657987123969394139236254
Total Assets
Total AssetsCr
117113128144143203210220240313458464

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1711044663-21824
Investing Cash Flow
Investing Cash FlowCr
-20-2-4-14-10-38-158-8-40-100
Financing Cash Flow
Financing Cash FlowCr
00617127-191382
Net Cash Flow
Net Cash FlowCr
-2023-510-210-1-96
Free Cash Flow
Free Cash FlowCr
170-2-19-69-2-1-8-29-76
CFO To PAT
CFO To PAT%
-154.0-12.627.67.6529.81,212.293.131.2-11.370.381.2
CFO To EBITDA
CFO To EBITDA%
-394.7-160.626.94.22,267.9879.355.814.7-6.355.865.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1711044663-21824
Investing Cash Flow
Investing Cash FlowCr
-20-2-4-14-10-38-158-8-40-100
Financing Cash Flow
Financing Cash FlowCr
00617127-191382
Net Cash Flow
Net Cash FlowCr
-2023-510-210-1-96
Free Cash Flow
Free Cash FlowCr
170-2-19-69-2-1-8-29-76
CFO To PAT
CFO To PAT%
-154.0-12.627.67.6529.81,212.293.131.2-11.370.381.2
CFO To EBITDA
CFO To EBITDA%
-394.7-160.626.94.22,267.9879.355.814.7-6.355.865.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4660105304125126261217627581446782
Price To Earnings
Price To Earnings
21.279.4147.734.235.520.842.921.814.832.2
Price To Sales
Price To Sales
2.22.12.13.72.41.82.31.64.12.91.93.3
Price To Book
Price To Book
0.40.61.02.51.11.01.91.53.62.91.62.7
EV To EBITDA
EV To EBITDA
-10.0-84.319.243.5687.424.626.212.526.419.714.223.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.245.541.935.333.735.335.741.544.543.142.142.1
OPM
OPM%
-20.8-2.410.38.50.47.69.112.615.715.915.515.9
NPM
NPM%
-53.3-31.010.14.61.65.55.45.98.812.612.59.5
ROCE
ROCE%
-10.7-9.15.56.91.84.16.910.012.215.712.09.9
ROE
ROE%
-10.3-8.84.73.20.73.04.55.77.712.310.67.8
ROA
ROA%
-9.6-7.94.02.70.61.93.03.85.78.06.44.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4660105304125126261217627581446782
Price To Earnings
Price To Earnings
21.279.4147.734.235.520.842.921.814.832.2
Price To Sales
Price To Sales
2.22.12.13.72.41.82.31.64.12.91.93.3
Price To Book
Price To Book
0.40.61.02.51.11.01.91.53.62.91.62.7
EV To EBITDA
EV To EBITDA
-10.0-84.319.243.5687.424.626.212.526.419.714.223.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.245.541.935.333.735.335.741.544.543.142.142.1
OPM
OPM%
-20.8-2.410.38.50.47.69.112.615.715.915.515.9
NPM
NPM%
-53.3-31.010.14.61.65.55.45.98.812.612.59.5
ROCE
ROCE%
-10.7-9.15.56.91.84.16.910.012.215.712.09.9
ROE
ROE%
-10.3-8.84.73.20.73.04.55.77.712.310.67.8
ROA
ROA%
-9.6-7.94.02.70.61.93.03.85.78.06.44.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,025874793782660486435
Close PriceClose₹511.9094.87147.80223.81285.00406.05762.60
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE10.5817.25278.8732.1629.2620.8915.14
Price To SalesPS1.422.541.923.283.993.111.15
RevenueRevenueCr722343414239165156378
Revenue Growth TTMRev Gr TTM%14.3%0.7%13.1%13.9%55.2%19.7%
PAT Growth TTMPAT Gr TTM%21.1%287.7%-68.6%-13.6%39.5%290.6%
Market CapitalizationMkt CapCr1,025874793782660486435
Close PriceClose₹511.9094.87147.80223.81285.00406.05762.60
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE10.5817.25278.8732.1629.2620.8915.14
Price To SalesPS1.422.541.923.283.993.111.15
RevenueRevenueCr722343414239165156378
Revenue Growth TTMRev Gr TTM%14.3%0.7%13.1%13.9%55.2%19.7%
PAT Growth TTMPAT Gr TTM%21.1%287.7%-68.6%-13.6%39.5%290.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews